Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 62% ± 22% | |
| CD4-positive, alpha-beta T cell | 5 studies | 19% ± 3% | |
| CD8-positive, alpha-beta T cell | 5 studies | 18% ± 1% | |
| deuterosomal cell | 4 studies | 35% ± 9% | |
| epithelial cell | 4 studies | 24% ± 5% | |
| retinal cone cell | 3 studies | 40% ± 14% | |
| retinal rod cell | 3 studies | 29% ± 8% | |
| dendritic cell | 3 studies | 23% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 779.03 | 180 / 180 | 99% | 33.18 | 426 / 430 |
| prostate | 100% | 556.83 | 244 / 245 | 99% | 16.92 | 497 / 502 |
| brain | 98% | 807.55 | 2597 / 2642 | 100% | 29.15 | 705 / 705 |
| thymus | 100% | 563.21 | 651 / 653 | 98% | 20.40 | 590 / 605 |
| skin | 99% | 741.20 | 1799 / 1809 | 97% | 24.29 | 460 / 472 |
| uterus | 100% | 822.02 | 170 / 170 | 97% | 30.69 | 444 / 459 |
| bladder | 100% | 537.43 | 21 / 21 | 96% | 23.82 | 483 / 504 |
| breast | 99% | 523.62 | 456 / 459 | 96% | 18.98 | 1078 / 1118 |
| lung | 99% | 718.08 | 574 / 578 | 95% | 21.79 | 1099 / 1155 |
| adrenal gland | 99% | 459.18 | 256 / 258 | 95% | 28.60 | 219 / 230 |
| intestine | 99% | 424.58 | 961 / 966 | 93% | 14.00 | 488 / 527 |
| kidney | 100% | 716.84 | 89 / 89 | 91% | 32.12 | 818 / 901 |
| esophagus | 93% | 352.86 | 1347 / 1445 | 89% | 13.95 | 163 / 183 |
| stomach | 96% | 343.98 | 343 / 359 | 86% | 10.05 | 247 / 286 |
| pancreas | 79% | 171.63 | 258 / 328 | 98% | 18.83 | 174 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 46.71 | 29 / 29 |
| spleen | 100% | 806.69 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.30 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.77 | 1 / 1 |
| adipose | 99% | 474.47 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 95% | 338.07 | 1268 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 11.99 | 75 / 80 |
| peripheral blood | 81% | 969.52 | 756 / 929 | 0% | 0 | 0 / 0 |
| heart | 69% | 155.18 | 598 / 861 | 0% | 0 | 0 / 0 |
| liver | 27% | 58.88 | 62 / 226 | 32% | 4.65 | 129 / 406 |
| muscle | 6% | 10.35 | 46 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060271 | Biological process | cilium assembly |
| GO_0002091 | Biological process | negative regulation of receptor internalization |
| GO_0043408 | Biological process | regulation of MAPK cascade |
| GO_0042058 | Biological process | regulation of epidermal growth factor receptor signaling pathway |
| GO_0005930 | Cellular component | axoneme |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0031982 | Cellular component | vesicle |
| GO_0042803 | Molecular function | protein homodimerization activity |
| Gene name | WDR54 |
| Protein name | WD repeat-containing protein 54 |
| Synonyms | |
| Description | FUNCTION: When cross-linked to form dimers and trimers, it has a regulatory effect on ERK signaling pathway activity in response to EGF stimulation. Colocalizes with the EGF receptor in WDR54-specific vesicle where it sustains the internalization and controls the degradation of the EGF receptor after EGF stimulation. . |
| Accessions | ENST00000348227.4 [Q9H977-1] ENST00000409791.5 [Q9H977-3] Q9H977 |
